Nákupy a predaje manažérov insider
| Kto | Čo | Hodnota | Dátum |
| Bourla AlbertChief Executive Officer |
nákup |
1,0 mil. | 12.08. |
| Damico Jennifer B.Officer |
predaj |
83 261 | 05.08. |
| Buckley Mortimer J.Director |
nákup |
960 369 | 05.08. |
| Blaylock Ronald EDirector |
nákup |
998 821 | 05.08. |
| Damico Jennifer B.Officer |
predaj |
51 400 | 09.06. |
| Damico Jennifer B.Officer |
odmena v akciách |
– | 03.03. |
| Boshoff ChristoffelOfficer |
odmena v akciách |
– | 25.02. |
| Sahni PayalOfficer |
uplatnenie opcií |
1,9 mil. | 25.02. |
| Mcdermott MichaelOfficer |
uplatnenie opcií |
1,3 mil. | 25.02. |
| Damico Jennifer B.Officer |
uplatnenie opcií |
593 812 | 25.02. |
| Bourla AlbertChief Executive Officer |
uplatnenie opcií |
16,6 mil. | 25.02. |
| Lankler Douglas MOfficer |
uplatnenie opcií |
4,2 mil. | 25.02. |
Predaje manažérov sú bežné (dane, diverzifikácia); nákupy z vlastných peňazí bývajú silnejší signál.
Kto vlastní akcie
Blackrock Inc.9,29 %
Vanguard Capital Management LLC6,53 %
State Street Corporation5,39 %
Geode Capital Management, LLC2,37 %
Vanguard Portfolio Management LLC2,09 %
Fisher Asset Management, LLC1,91 %
Morgan Stanley1,69 %
NORGES BANK1,08 %
O firme (popis z Yahoo Finance, anglicky)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
https://www.pfizer.com ↗